Home › Funds › Bain Capital Life Sciences Investors, LLC › KYTX

Bain Capital Life Sciences Investors, LLC position in KYTX

KYVERNA THERAPEUTICS INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 1,312,000 shares of KYTX (KYVERNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 0.61% of its reported portfolio and ranking #19 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed KYTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)1.31M sh
Reported value held$8.92M
Portfolio Weight0.61%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's KYTX position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in KYTX in Q1 2024 at 3,163,868 shares (US$78.6M). Across 11 filings, Bain Capital Life Sciences Investors, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,312,000 shares valued at US$8.9M — a reduction of -1,573,000 shares quarter over quarter.. Notable position changes include a 55% trim in Q3 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 3.16M $78.59M New
Q2 2024 3.37M $25.26M Add
Q3 2024 3.37M $16.47M Hold
Q4 2024 3.37M $12.60M Hold
Q1 2025 3.37M $6.50M Hold
Q2 2025 3.37M $10.34M Hold
Q3 2025 3.37M $20.21M Hold
Q4 2025 3.11M $29.23M Reduce
Q1 2026 3.11M $26.84M Hold
Q2 2026 2.88M $25.71M Reduce
Q3 2026 1.31M $8.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYTX and 13F data

KYTX (KYVERNA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in KYTX — the largest reported positions include GordonMD Global Investments LP (US$30.7M), GILEAD SCIENCES, INC. (US$28.1M), AIGH Capital Management LLC (US$24.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYTX

All KYTX fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held KYTX?

Bain Capital Life Sciences Investors, LLC has disclosed KYTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Bain Capital Life Sciences Investors, LLC's current position in KYTX?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 1.31M shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $8.92M, representing 0.61% of its reported portfolio and ranking #19.

Has Bain Capital Life Sciences Investors, LLC been buying or selling KYTX?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC reduced its position in KYTX.

Which other funds hold KYTX?

Other major institutional holders of KYTX include GordonMD Global Investments LP, GILEAD SCIENCES, INC., AIGH Capital Management LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.